Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS

NCT04557085 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial Seizure
Focal Seizure

Interventions

DRUG: Cenobamate
DRUG: Placebo

Sponsor

SK Life Science, Inc.